Recent evidence has suggested that vascular endothelial growth factor A (VEGFA) is an important regulator of ovarian follicle development and survival. Both LH and FSH regulate Vegfa expression in granulosa cells and signal via the transcription factor hypoxia inducible factor 1 (HIF1). To further study the mechanism of action of HIF1 in the regulation of Vegfa, we studied Vegfa delta/delta mice, which lack a hypoxia response element in the Vegfa promoter. Granulosa cells from Vegfa delta/delta mice failed to respond to FSH or LH with an increase in Vegfa mRNA expression in vitro, and granulosa cells isolated from eCG-treated immature Vegfa delta/delta mice had significantly lower Vegfa mRNA levels compared to controls. However, normal Vegfa mRNA levels were detected in the granulosa cells from immature Vegfa delta/delta mice following hCG treatment. Vegfa delta/delta females produced infrequent litters, and their pups died shortly after birth. Ovaries from Vegfa delta/delta mice were much smaller than controls and contained few antral follicles and corpora lutea. Antral follicles numbers were decreased by nearly 50% in ovaries from Vegfa delta/delta mice relative to controls, and 74% of antral follicles in Vegfa delta/delta ovaries were atretic. Serum progesterone levels in adult Vegfa delta/delta females were significantly lower, apparently reflecting reduced numbers of corpora lutea. This study demonstrates for the first time the requirement of HIF1 for FSH-regulated Vegfa expression in vivo and that HIF1 acts via a single hypoxia response element in the Vegfa promoter to exert its regulatory functions. Our findings also further define the physiological role of VEGFA in follicle development. follicular development, granulosa cells, HIF1, VEGFA
INTRODUCTION
Whereas the pituitary gonadotropins FSH and LH are the best-known endocrine regulators of ovarian follicular growth and development, a large number of locally produced, locally acting ovarian factors are also required for these processes to occur normally. These include insulin-like growth factor-1 (IGF1), steroid hormones, epidermal growth factor-like molecules, and several transforming growth factor-b (TGFb) superfamily members [1] [2] [3] [4] . Together, these molecules act to modulate and coordinate follicular responses to the gonadotropins, and their activities are indispensable for the series of events leading up to (and following) the release of the oocyte at the moment of ovulation.
Another potentially critical autocrine/paracrine regulator of follicle development is vascular endothelial growth factor A (VEGFA). VEGFA is a member of the VEGF family of cysteine-knot growth factors and is best known for the essential roles that it plays in angiogenesis, acting to stimulate both endothelial cell mitosis and migration [5] . In the ovary, VEGFA expression in follicular granulosa cells increases as ovulation approaches, suggesting that VEGFA mediates the vascular infiltration of the granulosa cell layer that occurs during the formation of the corpus luteum [6] . Though this may be the case, VEGFA is also expressed in follicles well before the preovulatory stage, leading several investigators to propose additional biological functions [7] . Most notably, several converging lines of evidence indicate that VEGFA is required for follicle survival and functions to suppress apoptosis in granulosa cells. For instance, VEGFA treatment of cultured granulosa cells greatly increases their resistance to apoptosis [8] [9] [10] , and injection of VEGFA into the ovary promotes follicle development and decreases apoptosis [11] . Conversely, the intrabursal administration of a soluble VEGF inhibitor greatly increases granulosa cell apoptosis in antral follicles [12, 13] , and follicular atresia in normal cycling ovaries is associated with the loss of expression of the VEGFA receptor, VEGFR2 (FLK-1) [8] . Another recent study showed that overexpression of VEGF 165 b (an antiangiogenic isoform of VEGFA) in a transgenic mouse model resulted in reduced female fertility, with ovaries featuring reduced numbers of secondary and tertiary follicles and corpora lutea and increased follicular atresia [14] .
A major transcriptional regulator of Vegfa in several tissues and physiological contexts is the transcription factor hypoxia inducible factor-1 (HIF1) [15, 16] . HIF1 consists of HIF-1a and HIF-1b subunits, the former being rapidly degraded under normoxic conditions, whereas the latter is constitutively expressed in most cell types. Hypoxia slows the HIF-1a degradation process, permitting its accumulation and nuclear translocation. In the nucleus, the a and b subunits dimerize and bind to hypoxia response elements (HREs) located in the promoters of a number of transcriptional target genes [17] . Although hypoxia is generally considered the main regulator of HIF1 activity, it can also be controlled by oxygen-independent mechanisms. For instance, a number of signaling molecules, including Il-1b, TNF-a, TGF-b, FGF-2, and IGF-1, and the PI3K/AKT and MAPK pathways can act to increase the translation of Hif1a mRNA and/or alter the transactivation properties of HIF1 via different mechanisms [18] [19] [20] . Several recent reports have shown that HIF1 is a major regulator of ovarian gene expression and that it appears to be a critical mediator of the processes of follicle development and ovulation [21] [22] [23] [24] . Among the main transcriptional targets of HIF1 identified in granulosa cells to date is Vegfa. Indeed, HIF1 has been shown to be required for LH-regulated Vegfa expression in vitro and in vivo [23, 25, 26] as well as for FSH-regulated Vegfa expression in vitro [21, 22] . The mechanisms whereby LH regulates HIF activity in this context have not been reported, but regulation of HIF1 by FSH would appear to require both PI3K/AKT/mTOR and ERK signaling [22] . The mechanisms of regulation of Vegfa transcriptional activity by HIF1 in granulosa cells remain unknown.
In the present study, we aimed to further define the role and mechanism of action of HIF1 in the regulation of Vegfa by the gonadotropins in vivo. We sought to determine the role of a previously characterized HRE in the Vegfa promoter for FSHand LH-regulated Vegfa expression as well as to study the physiological consequences of ovarian VEGFA deficiency using a transgenic mouse model.
MATERIALS AND METHODS

Animal Model and Breeding Trial
C57BL/6J mice (referred to herein as wild type [WT]) were obtained from the Jackson Laboratory. Vegfa d/d mice, originally described in [27] , were generated by mating males and females heterozygous for the transgenic allele (i.e., Vegfa d/þ ) and were maintained on a C57BL/6 genetic background. Genotyping analyses were performed by PCR on DNA obtained from tail biopsies using the oligonucleotide primers 5 0 -GCTTATCTGAGCCCTTGTCT GATC-3 0 (Vegfa genotype S); 5 0 -GATGAACCGTAAGCCTAGGCTAG-3 0 (Vegfa genotype AS); 5 0 -GAGTGAGACGACCTGTGGAAATG-3 0 (mutant-HRE-S); and 5 0 -AGACTACACAGTGCATACGTGGGT-3 0 (WT-HRE-AS). The following PCR conditions were used: 1 min at 948C for one cycle, 30 sec at 948C, 30 sec at 608C, and 30 sec at 728C for 29 cycles, and 10 min at 728C for one cycle. Primers were designed to generate PCR products of 482 bp and 208 bp for the WT Vegfa allele, or 482 and 303 bp for the Vegfa d allele. The breeding trial was conducted using 8-wk-old Vegfa d/d (n ¼ 6) and control littermate Vegfa þ/þ (n ¼ 6) female mice. Adult C57BL/6J males were placed in the cages for 3 mo, and the experiment was terminated 21 days after their removal to allow for the final litter. The breeding trial was limited to 3 mo because Vegfa d/d mice are known to develop a (potentially confounding) neurodegenerative condition after the age of 5 mo [27] . All the animal procedures were approved by the institutional animal care and use committee and conformed to the International Guide Principles for Biomedical Research Involving Animals as promulgated by the Society for the Study of Reproduction.
Tissue Collection and Follicle Counting
Ovaries and granulosa cells from immature mice were obtained 48 h after treatment with 5 international units (IU) intraperitoneally (i.p.) of equine chorionic gonadotropin (eCG) (Folligon; Intervet) with or without the subsequent administration of an ovulatory dose of 5 IU i.p. of human chorionic gonadotropin (hCG) (Chorulon; Intervet). Intact ovaries used for histology were fixed with formalin before being paraffin embedded. Granulosa cells were isolated by placing ovaries in Hanks balanced salt solution and puncturing with 26-gauge needles to release the granulosa cells as previously described [28] . For follicle counting analyses, both left and right ovaries were collected, fixed in Bouin fixative for 48 h, and washed for 2 days with 70% ethanol before being paraffin embedded. Serial sections were prepared at a thickness of 6 lm, and every sixth section was stained with hematoxylin and eosin. Photomicrographs of all the follicles containing a visible oocyte nucleus were taken for all of the sections. Blind classification of the follicles based on the Pedersen system was then performed as previously described [29] .
Real-Time RT-PCR
Total RNA from granulosa cells was extracted using the RNeasy Mini Kit (Qiagen) according to the manufacturer's protocol. Total RNA was reverse transcribed using 100 ng of RNA and the SuperScript Vilo cDNA synthesis kit (Invitrogen). Real-time PCR reactions were run on an ABI Prism 7300 instrument using Power SYBR Green PCR Master Mix (4367659; Applied Biosystems). Each PCR reaction consisted of 12.5 ll of Power SYBR Green PCR Master Mix, 9.5 ll of water, 1 ll of cDNA sample, and 1 ll of genespecific primers (10 pmol). PCR reactions run without cDNA (water blank) served as negative controls. A common thermal cycling program (3 min at 958C, 40 cycles of 15 sec at 958C, 30 sec at 608C, and 30 sec at 728C) was used to amplify each transcript. To quantify relative gene expression, the Ct of target gene amplification was compared with that of Rpl19 according to the ratio,
, where E is the amplification efficiency for each primer pair. Rpl19 Ct values did not change significantly between genotypes and treatments, and Rpl19 was therefore deemed suitable as an internal reference gene as other groups have previously shown [30] . The specific primer sequences used are listed in Supplemental Table S1 (all the supplemental data are available online at www.biolreprod.org).
Immunohistochemistry and Immunofluorescence
Ovaries were formalin-fixed, paraffin-embedded, and sectioned at a thickness of 4 lm with a microtome. Sections were incubated with cleaved caspase-3 antibody (9661S; Cell Signaling Technology) using the manufacturers' suggested conditions, and subsequently probed with a secondary biotinylated goat anti-rabbit antibody (Vector Labs). Negative controls were run omitting the primary antibody. Staining was performed using the 3,3
0 -diaminobenzidine peroxidase substrate kit (SK-4100; Vector Labs) as directed, and slides were briefly counterstained with hematoxylin prior to mounting.
For immunofluorescence experiments, ovaries were embedded in optimal cutting temperature compound (Sakura Finetek) and stored at À808C before the preparation of 4 lm sections, which were fixed for 30 min in cold acetone. Sections were labeled with a primary antibody against PECAM (558736; BD Biosciences) in phosphate-buffered saline with 3% goat serum overnight at 48C, and subsequently probed with a secondary Alexa Fluor 594-conjugated goat anti-rat antibody (Molecular Probes) for 1 h at room temperature. Slides were mounted using Vectashield with 4 0 ,6-diamidino-2-phenylindole (Vector Laboratories).
Cell Culture
For Vegfa mRNA expression analysis, granulosa cells from WT or Vegfa
mice were seeded in 96-well plates (cells recovered from 0.2 ovary/well) at 378C with 5% CO 2 in MEM containing 1% fetal bovine serum, 0.25 nM sodium pyruvate, and 3 mM L-glutamate, for 24h. The following day, after a serum starvation of 3h, granulosa cells were treated (or not) with 50 nM echinomycin (330175; Millipore) for 1 h and subsequently treated (or not) with 50 ng/ml recombinant human FSH or LH (National Hormone and Peptide Program), or 200 lM CoCl 2 (15862; Invitrogen). At the end of the culture period, granulosa cell were lysed with RLT buffer (Qiagen) and stored at À808C until total mRNA extraction.
For HIF1a regulation analyses, granulosa cells from WT mice were seeded in 48-well plates (cells recovered from 1 ovary/well) at 378C with 5% CO 2 in MEM containing 1% fetal bovine serum, 0.25 nM sodium pyruvate and 3 mM L-glutamate, for 24 h. The following day, after a serum starvation of 3 h, granulosa cells were treated with or without FSH and LH (50 ng/ml) and CoCl 2 (200 lM) for 2 h. At the end of the culture period, granulosa cell were lysed with SDS loading buffer (50 mM Tris-HCl, pH 6.8, 2% SDS, 10% glycerol, 1% b-mercaptoethanol, 12.5 mM ethylenediaminetetraacetic acid, and 0.02% bromophenol blue) and then stored at À808C prior to immunoblotting.
Steroid Hormone Measurements
Estradiol (E2) and progesterone (P4) levels in the serum were determined by enzyme-linked immunosorbent assay and radioimmunoassay, respectively, and FSH and LH levels in the serum were determined by multiplex testing (Calbiotech). All the assays were performed by the ligand assay and analysis core laboratory of the University of Virginia (Charlottesville, VA).
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Statistical Analyses
All the data are presented as mean 6 SEM. All the data sets (ovary weights, follicle numbers, mRNA expression, protein expression, and steroid hormone levels) were subjected to the F-test to determine equality of variances. Log transformation of the data was done prior to further statistical analysis when unequal variances were detected. Two-tailed t-tests were used when two experimental groups were compared, or ANOVA in the case of three or more groups. In the event that log transformation did not resolve unequal variances, the nonparametric Mann-Whitney (two groups) or Kruskal-Wallis (three or more groups) tests were used. A P , 0.05 was considered statistically significant. Analyses were done using Prism 4.0a (GraphPad Software Inc.) software.
RESULTS
HIF1 Acts Through a Single HRE in the Vegfa
To study the involvement of HIF1 in the regulation of Vegfa expression by gonadotropins in the ovary, cultured granulosa cells from eCG-primed immature WT mice were pretreated or not for 1 h with echinomycin, a peptide antibiotic that acts by intercalating into DNA specifically at the HRE, thereby blocking the binding of HIF1 [31, 32] , and then incubated for 2 h with FSH, LH, or CoCl 2 , a hypoxia mimetic that stabilizes the HIF1a protein (i.e., positive control). FSH, LH, and CoCl 2 treatment all resulted in significant increases in Vegfa mRNA expression (Fig. 1A) . Alone, echinomycin had no effect on Vegfa mRNA expression in granulosa cells, but it effectively abolished the induction of Vegfa expression by FSH, LH, or CoCl 2 (Fig. 1A) .
To elucidate the mechanism whereby HIF regulates Vegfa transcriptional activity, a similar in vitro experiment was conducted using granulosa cells isolated from eCG-primed immature WT or Vegfa d/d mice. The Vegfa d allele lacks a wellcharacterized HRE in the Vegfa promoter [33, 34] . Whereas a significant increase in Vegfa mRNA levels were obtained following FSH or LH treatment in WT granulosa cells, granulosa cells from Vegfa d/d mice failed to respond to FSH or LH with an increase in Vegfa mRNA expression (Fig. 1B) . Together, these results confirm the previously reported [21] [22] [23] [24] [25] [26] requirement of HIF1 for gonadotropin-regulated Vegfa expression in granulosa cells and pinpoint a single HRE in the Vegfa promoter that is required for HIF1-mediated regulation of Vegfa transcription and gonadotropin responsiveness in granulosa cells in vitro.
The Vegfa Promoter HRE Is Required for FSH Responsiveness In Vivo
To determine if gonadotropin-regulated Vegfa expression also requires HIF1 activity and the Vegfa promoter HRE in vivo, Vegfa mRNA levels were measured in granulosa cells isolated from immature WT and Vegfa d/d mice treated with eCG (FSH mimetic) for 48 h followed or not by hCG (LH mimetic) for 12 h. In agreement with our in vitro observations, granulosa cells from Vegfa d/d mice had significantly lower Vegfa mRNA levels following eCG treatment ( Fig. 2A) , indicating a requirement of HIF1 (and the Vegfa promoter HRE) for FSH-regulated Vegfa expression. However, unlike what was observed in vitro, Vegfa mRNA levels in the granulosa cells from hCG-treated mice were comparable to WT controls (Fig. 2B) , suggesting that other mechanism(s) offset the loss of the Vegfa HRE to permit normal LH responsiveness in the Vegfa d/d model. Importantly, the expression of FSHresponsive genes (Cyp19a1, Inha) and LH-responsive genes (Star, Adamts1, Pgr) were normal in granulosa cells from Vegfa d/d mice, indicating that gonadotropin responsiveness was not globally altered (Supplemental Figure S1 ). Reduced Vegfa mRNA levels were also observed in whole ovaries from adult mice (Fig. 2C) . Interestingly, we found no evidence of altered Vegfa expression in the Vegfa d/d ovary other than in follicular granulosa cells. Residual cells, consisting of the remaining ovarian stroma following extraction of granulosa cells by needle puncture, showed equal levels of Vegfa mRNA in WT and Vegfa d/d ovaries (Fig. 2D ) and equal mRNA levels of the endothelial cell markers Cd31 and Vwf (data not shown). Furthermore, histological analyses and CD31 (PECAM1) immunofluorescence studies showed no clear differences in the vascular development of the corpora lutea (when present) or ovarian stroma when WT and Vegfa d/d ovaries were compared (Fig. 3 as well as data not shown) . Together, these data suggest that HIF1-mediated transcriptional activation via the Vegfa promoter HRE is more critical to FSH-regulated Vegfa expression in granulosa cells and is dispensable for LHmediated regulation of Vegfa or for Vegfa expression in other ovarian cell types in vivo. females were previously described as sterile [27] , three of the females produced one litter each, whereas all the control mice produced two to three litters during the breeding trial. All the pups born of Vegfa d/d females appeared normal at birth but died within 48 h for undetermined reasons.
FIG. 1. HIF1 is required downstream of FSH/LH to regulate
To elucidate the basis for the infertility observed in female Vegfa d/d mice, histopathological analyses of the ovaries were done in immature (26 days) and adult animals. Ovaries from 26-day-old Vegfa d/d mice were morphologically indistinguishable from controls, and were of a similar weight (Table 1 as well as data not shown). However, ovaries from adult Vegfa
mice were grossly abnormal. These ovaries were much smaller than ovaries from age-matched controls (Table 1) and appeared largely (and often completely) devoid of large antral follicles and corpora lutea (Fig. 4A) . A quantitative analysis of the ovarian reserve of young adult Vegfa d/d mice showed numbers of primordial, primary, and secondary follicles that were comparable to controls and normal rates of atresia (Fig. 4 , B and C), although the number of secondary follicles trended to be lower ('34% less than control, P , 0.1) in the Vegfa
group. The biggest difference occurred in antral follicles, whose numbers were decreased by nearly 50% in ovaries from Vegfa d/d mice relative to controls. Furthermore, 74% of antral follicles in Vegfa d/d ovaries were categorized as atretic, a proportion that was markedly higher than in controls (Fig. 4, B and C). Increased atresia was confirmed by activated caspase-3 immunohistochemistry, which showed a vastly greater incidence of granulosa cell apoptosis in large follicles in Vegfa
ovaries (Fig. 4D) . Despite the lower numbers of healthy follicles, circulating E2 levels in adult Vegfa d/d females were comparable to controls (Table 2) . However, P4 levels were significantly lower, apparently reflecting reduced numbers of corpora lutea in adult Vegfa d/d ovaries. These results show that even a moderate decrease in Vegfa expression in granulosa cells compromises follicle development and viability, resulting in decreased female fertility.
Finally, to confirm that increased follicular atresia in Vegfa females and controls in the expression of either gonadotropin subunit or in serum hormone levels (Fig. 5) , suggesting that the follicle atresia phenotype observed in the Vegfa d/d model is ovary autonomous and not due to a lack of gonadotropin support. 
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DISCUSSION
Whereas several studies have established that HIF1 is an important mediator of Vegfa responsiveness to the gonadotropins in granulosa cells in vitro, its potential role in vivo is not well established, nor have the mechanisms whereby HIF1 regulates Vegfa promoter activity been defined in this cell type.
In this study, we demonstrate for the first time the requirement of a single HRE in the Vegfa promoter that is required for FSHregulated Vegfa expression in vivo. These results substantiate and add mechanistic detail to previous studies showing a requirement of HIF1 in FSH-mediated regulation of Vegfa in vitro [21, 22] and providing evidence of their relevance in a physiological context.
In agreement with previous studies [23, 25, 26] , we found that HIF1 is required for the regulation of Vegfa by LH in cultured granulosa cells. Unexpectedly however, granulosa cells isolated from Vegfa d/d ovaries 12 h post-hCG showed normal levels of Vegfa expression, indicating a normal response of the Vegfa gene to LH in vivo. This finding appears to contradict an earlier study [23] showing that treatment of mice with echinomycin 6 h after hCG administration effectively blocks the induction of Vegfa by hCG. While the reason for this discrepancy is unclear, it may be the result of the differences in the experimental approach. For example, whereas the administration of echinomycin could be expected to interfere with the transcriptional activity of all the genes with an HRE, our genetic approach targeted only the HRE within the Vegfa promoter. Echinomycin may therefore have affected Vegfa regulation in an indirect manner (i.e., by altering the transcriptional activity of genes that in turn regulate Vegfa), unlike the Vegfa d/d model that permits the study HIF1-dependent signaling processes that directly regulate the Vegfa promoter. Notwithstanding, the discrepancy between the apparent HIF1 dependence of LH-regulated Vegfa expression that we observed in vitro and its apparent HIF1 independence in vivo remains unexplained. One possible explanation is that LH activates additional, HIF1-independent signaling processes that regulate Vegfa in granulosa cells in vivo but not in vitro and WT mice. Ovaries were fixed in formalin prior to being paraffin embedded, and 4 lm sections were counterstained with hematoxylin-phloxine-safran for histological analysis. AF: antral follicle, CL: corpus luteum, SF: small follicle. B and C) Quantitative analysis of ovarian follicles from 12-wk-old mice. Ovaries (n ¼ 5 animals per genotype) were serially sectioned, and all the follicles from every sixth section were counted, categorized as primordial, primary, secondary, or antral, and scored as either healthy or atretic. Data represent raw follicle count numbers and were not adjusted to estimate the total ovarian follicle population. All the data are expressed as means 6 SEM (columns and error bars). Asterisks indicate statistically significant differences (*P , 0.05 and **P , 0.01) between genotypes. D) Activated-caspase-3 immunohistochemistry done on ovaries from 8-wkold WT and Beyond providing new information regarding regulatory mechanisms of Vegfa gene expression in the ovary, our study also provides insight into the physiological roles of VEGFA in follicle development. Our finding that antral follicle abundance decreased and atresia increased in the Vegfa d/d model relative to WT is fully compatible with older studies that employed intraovarian or intrabursal administration of VEGFA or VEGFA inhibitors [11] [12] [13] . They are also very similar to a study by Qiu et al. [14] that also used a genetic approach to study Vegfa function. These authors studied a transgenic model that overexpresses the antiangiogenic VEGFA isoform VEGF 165 b and found reduced female fertility, reduced numbers of secondary and tertiary follicles and corpora lutea, and increased follicular atresia. Our study however is the first to use a genetic approach to target Vegfa expression directly, thereby avoiding potential nonspecific effects of inhibitors. Perhaps one of the most interesting aspects of our findings is that a relatively modest knockdown of Vegfa expression (2-to 3-fold) in the granulosa cells of eCG-primed follicles resulted in such a marked follicle development/survival phenotype. This apparently critical dose sensitivity is not completely surprising given that mice that are heterozygous for a null Vegfa allele (Vegfa þ/À ) die during embryogenesis, indicating that a global loss of 50% of Vegfa expression is incompatible with life [35] . Whereas our study demonstrated that a marked follicle development defect occurs in the Vegfa d/d model, we were not able to attribute the reduced fertility that we observed solely to the ovarian phenotype. Although pituitary function appears intact, we cannot rule out oviduct or uterine abnormalities that may have affected the establishment and/or maintenance of pregnancy. Likewise, the death of the pups from Vegfa d/d mothers may have resulted from a lactation defect, but we were not able to assess this. Ultimately, a conditional, granulosa cell-targeted knockout approach will be required to fully dissect the ovarian role of VEGFA from its potential roles in other reproductive tissues.
An important question raised by the present study is the mechanism whereby FSH regulates HIF1 activity. HIF1 activity is typically thought of as being regulated primarily at the level of the stability of the HIF-1a protein [18] . However, Alam et al. [22] found that FSH can increase HIF1 translational activity without an appreciable change in transcription levels. Indeed, a change in HIF-1a protein expression was only observed in cells that were treated concomitantly with FSH and CoCl 2 [22] . Several studies have shown that different signaling molecules and pathways can modulate HIF1 activity via mechanisms that do not involve stabilization of the HIF-1a subunit. For instance, regulatory associated protein of mTOR (Raptor) interacts with HIF-1a and enhances its activity by increasing its association with p300/CBP [36] . Similarly, ERK signaling can stimulate HIF1 activity at least in part by directly phosphorylating p300, thereby facilitating its interaction with the HIF-1a transactivation domain [37] . Both aforementioned mechanisms may be relevant to FSH regulation HIF1 translational activity because both mTOR and ERK signaling seem to be required [22] . Further studies will therefore be needed to fully elucidate the mechanisms of FSH-HIF1 signaling.
In summary, this article shows for the first time that HIF1 acts via a specific HRE in the Vegfa promoter to mediate FSHregulated Vegfa expression in granulosa cells in vivo. Loss of this regulatory process through deletion of the Vegfa HRE in the Vegfa d/d model resulted in a Vegfa expression defect that markedly compromised antral follicle development and female fertility. These findings further define the role of VEGFA in ovarian physiology and provide insight into the mechanisms of its regulation by FSH.
